A comprehensive view of liver/kidney/bladder health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Olympus announces strategy to sharpen focus on gastrointestinal, urological and respiratory care; approach includes expanded global R&D network, centralized quality assurance and regulatory affairs functions, strong merger and acquisition momentum
Published: December 07, 2021 by Olympus Corp.
Merck announces European Commission approval of KEYTRUDA intravenous infusion plus oral LENVIMA as first-line treatment of advanced renal cell carcinoma
Published: November 30, 2021 by Merck & Co. Inc.
Wacker enters agreement to manufacture Prokarium’s microbial novel immunotherapy for bladder cancer; Wacker will ramp up production from its site in Amsterdam
Published: October 12, 2021 by Wacker Chemie AG
Olympus highlights expanded urology devices portfolio at American Urological Assn. virtual meeting; products include iTind minimally invasive procedure for enlarged prostate, SOLTIVE SuperPulsed system for kidney and ureteral stones
Published: September 09, 2021 by Olympus America Inc.
AstraZeneca announces approval in Japan for oral Forxiga for treatment of chronic kidney disease in adults with or without type 2 diabetes
Published: August 26, 2021 by AstraZeneca AB

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count